Follow the 디앤디파마텍 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 디앤디파마텍 has logged 36 public disclosures. Market capitalisation: €2,610.7bn. The latest transaction was filed on 11 June 2026 (Purchase). Among the most active insiders: 신재희. The full history is openly available.
36
Insider Decl.
n/a
Thresholds
n/a
18 ops.
Buy Volume
n/a
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,022 of 27,906 companies
42.6
score / 100
Value
31
Quality
54
FCF yld-1.0%
Earn yld-1.1%
EV/EBITDA·
ROE-35%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
디앤디파마텍 is a company listed on the XKRX market, specializing in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions for disease treatment.